The aim of this International Menopause Society White Paper on premature ovarian
insufficiency (POI) is to provide the latest information regarding this distressing condition …

Many factors in the domains of mental, physical, and social health have been associated
with various ocular surface diseases, with most of the focus centered on aspects of dry eye …

Cyclophosphamide (CTX) is a chemotherapeutic agent widely used to treat ovarian, breast,
and hematological cancers as well as autoimmune disorders. Such chemotherapy is …

Background: Over the past decades, advancements in oncological treatments have led to
major improvements in survival. Particularly for adolescents and young adults (AYAs) …

Physical and mental health and hormonal imbalance are associated with the problems
related to infertility and reproductive disorders. The rate of infertility has increased globally …

Simple Summary As cancer treatments become more effective and many patients have long
term survival, concerns related to patient's quality of life and reproductive health become …

Natural menopause typically occurs between the ages of 46–55 years. Premature ovarian
insufficiency or premature menopause results from compromised ovarian follicular activity …

Annually,~ 50,000 patients undergo hematopoietic stem cell transplantation (HCT)
worldwide with almost 22,000 of these patients receiving HCT in the United States. HCT is a …

Autologous haematopoietic stem cell transplantation (AHSCT) is a treatment option for
aggressive forms of multiple sclerosis (MS) that has been derived from haematological …

Background Autologous hematopoietic stem cell treatment (AHSCT) is considered an
effective treatment option for patients with aggressive relapsing-remitting multiple sclerosis …